Litigation

Recent Posts

Supreme Court: Generic Drug Makers Not Liable For Warnings
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court on Thursday ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the brand-name equivalents of the medicines... Read More

Tags: Supreme Court , drugs , Actavis Elizabeth LLC v. Mensing , Gladys Mensing , warnings , Pliva Inc. , Litigation , labels , failure to warn , generic drugs , Actavis Inc. v. Demahy , Julie Demahy , Teva , PLIVA Inc. v Mensing , medicine , Wyeth v. Levine

U.S. Supreme Court To Decide Whether Claims About Generic Drugs Are Preempted
Posted on 13 Dec 2010 by Tom Moylan

WASHINGTON, D.C. -- (Mealey's) The U.S. Supreme Court on Dec. 10 agreed to decide whether the Hatch Waxman Act prevents manufacturers of generic drugs from adding new warnings to drug labels as new risks become known ( Pliva, Inc. v. Gladys Mensing... Read More

Tags: drug labels , Inc. v. Gladys Mensing , Hatch Waxman Act , Actavis Elizabeth , personal injury , Gladys Mensing , LLC v. Gladys Mensing , product liability , tardive dyskinesia , Parkinson's disease , Pliva Inc. , Litigation , Pliva , generic drugs , metoclopramide , Reglan , U.S. Supreme Court , torts